77 Elektronika Kft.
Letter data
- Company
- 77 Elektronika Kft.
- Recipient
- Sandor Zettwitz | Managing Director | 77 Elektronika Kft. | Budapest | Fehervari ut 98 | 1116 | Hungary
- Issue date
- 2020-05-29
- Posted date
- Not available
- FDA office
- "OHT7: Office of In Vitro Diagnostics and Radiological Health, Office of Product Evaluation and Quality"
- Subject
- Not available
- Product
- Medical Devices
- CMS ID
- 458367
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
77 Elektronika Kft.
MARCS-CMS 458367 —
May 29, 2020
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Product:
Medical Devices
Recipient:
Recipient Name
Sandor Zettwitz
Recipient Title
Managing Director
77 Elektronika Kft.
Budapest
Fehervari ut 98
1116
Hungary
Issuing Office:
"OHT7: Office of In Vitro Diagnostics and Radiological Health, Office of Product Evaluation and Quality"
United States
Dear Mr. Zettwitz:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter (CMS #458367 dated October 8, 2015). Based on our evaluation, it appears that your firm has addressed the violations contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely yours,
/S/
Courtney H. Lias, Ph.D.
Deputy Director for Patient Safety and Product
Quality
Office of In Vitro Diagnostics and Radiological
Health
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Content current as of:
06/12/2020
Regulated Product(s)
Medical Devices